As reported in UCSF news site, the preeminent San Francisco-based research center has received $26.2 million from the U.S. Army Medical Material Development Activity to develop treatments for traumatic brain injury. USSF is leading a consortium known as The Transforming Research and Clinical Knowledge in Traumatic Brain Injury Network (TRACK-TBI NET), which will lead phase II clinical trials in 18 hospitals with Level 1 trauma centers. The principal investigator, Geoffrey Manley, reports that with over 30 clinical trials for TBI there are still no effective drugs.

Lead Research/Investigator:

Geoffrey Manley


Source: UCSF

Pin It on Pinterest